Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting "FOR" the Company's Highly Qualified Director Nominees LEXINGTON, Mass., May 08, 2025 ...

The Board of Directors continues to recommend stockholders vote “FOR” its three director nominees, Mary Ann Gray, Ph.D, Ran Nussbaum and Alpna Seth, Ph.D, at the upcoming 2025 Annual Meeting, which is ...

Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

Just like many of The Ordinary’s bestselling products, the growth factor 15 percent solution comes in the brand’s signature ...

A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and neck squamous cell ...

Innovative antisense therapy blocking production of TGF-β2 shows promise in reducing retinal fibrosis and improving outcomes ...

Keros' cash and cash equivalents as of March 31, 2025 was $720.5 million compared to $559.9 million as of December 31, 2024.

Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA 1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...

In addition to buzzy ingredients like exosomes and PDRN, growth factor serums are another type of futuristic formula on the ...

Sperm swim faster in high temperature environments; aging ovaries slowly lose egg support. Both affect fertility differently.

How to judge a good - and disastrous - night for Labour, Reform and Tories - NEWS ANALYSIS: The Independent’s political ...

29/04/25 We have updated the quest list below with information on accessing the deluxe edition content. What is the complete Oblivion Remastered quest list? If you're jumping into the RPG for the ...